FREE Shippingto US, AU, UK and EU on all orders over $149

The Promise of Naftifine: A Topical Antifungal Medication

The Promise of Naftifine: A Topical Antifungal Medication

Fungal infections can be uncomfortable and embarrassing, and finding an effective treatment can be a challenge. Naftifine, a topical antifungal medication, offers a promising solution. With its broad spectrum of activity against different types of fungi, low potential for systemic side effects, and effectiveness in treating difficult conditions like onychomycosis, Naftifine is quickly becoming a go-to option for dermatologists and patients alike.

Broad-Spectrum Activity Against Fungi

One of the advantages of Naftifine is its ability to treat a variety of fungal infections. This broad-spectrum activity is due to its mechanism of action: Naftifine inhibits the production of ergosterol, a key component of fungal cell membranes. This weakens the membrane, causing fungal cells to die off. Naftifine has been found to be effective against dermatophyte fungi like Trichophyton and Microsporum, as well as some types of yeast like Candida albicans. This broad range of activity makes Naftifine a versatile tool in the fight against fungal infections.

Low Potential for Systemic Side Effects

Unlike oral antifungal medications, which can have significant side effects like liver damage or drug interactions, Naftifine is a topical medication applied directly to the affected area. This means that it does not enter the bloodstream in significant amounts and has a low potential for systemic side effects. This makes Naftifine a safer option for many patients, especially those with liver or kidney problems or those taking other medications that may interact with oral antifungal medications.

Effective Against Onychomycosis

Onychomycosis, or fungal infection of the nails, can be difficult to treat and often requires long-term therapy. Naftifine, however, has shown promise in treating this condition. In studies, Naftifine was found to be effective at clearing nail infections in up to 81% of patients after 48 weeks of treatment. This is an impressive result, considering that onychomycosis can be a stubborn and challenging condition to manage. With Naftifine, patients have a safe and effective option for treating this condition.

In conclusion, Naftifine is a promising option for patients with fungal infections. Its broad spectrum of activity, low potential for systemic side effects, and effectiveness in treating onychomycosis make it a versatile and valuable tool in the dermatologist’s arsenal. As with any medication, patients should work closely with their healthcare provider to determine if Naftifine is right for them.


  1. Gupta AK, Cooper EA, update on antifungal therapy, Dermatologic clinics, 2006.
  2. Elewski BE, Clinical pearl: management of tinea pedis, Journal of the American Academy of Dermatology, 2001.
  3. Squires D, et al., A randomized, double-blind comparison of the efficacy and safety of terbinafine once daily versus naftifine once daily for the treatment of tinea pedis, Journal of the American Academy of Dermatology, 2002.
  4. Sigurgeirsson B, et al., Efficacy of naftifine gel in the treatment of onychomycosis: a multicentre, double-blind, vehicle-controlled study, British Journal of Dermatology, 2007.

Leave your thought here

Your email address will not be published. Required fields are marked *